← Leaderboards
Hui Mao
Emory University
$16,442,940
Attributed
$26,105,675
Total exposure
20
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,105,675 · 20
By mechanism
R01$13,536,089 · 6
U01$5,859,335 · 3
S10$2,000,000 · 1
R41$1,019,657 · 3
P50$896,829 · 1
R42$888,723 · 1
Top collaborators
- Lily Yang35 shared
- Y Andrew Wang6 shared
- Yuancheng Li5 shared
- Xiaodong Zhong3 shared
- Mark Myron Goodman2 shared
- Peter B Barker1 shared
- Zahra Hosseini1 shared
- Zhi-Pei Liang1 shared
Most similar at Emory University
Same institution · by research overlap
- Lily Yang$15,527,458
- Yuesong Hu$278,044
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingMonitorTumorTissuesMagnetismNanoparticleMalignant NeoplasmsTreatment ResponseImageDetectionLigandsChemotherapyBiodistributionResponseUrokinase Plasminogen Activator ReceptorTargeted DeliveryLeadPharmaceutical PreparationsDesignIn VivoNeoplastic CellIron OxideIn VitroDrug Delivery Systems
Grant awards (67)
Development of "Imagnostix": A Liquid Biopsy System for Alzheimer's Disease$888,723
R42 · FY2025 · AG
Fast high-resolution simultaneous metabolic and multiparametric imaging of the whole brain$700,067
U01 · FY2025 · EB
High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease$555,212
R01 · FY2025 · AG · contact PI
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$472,215
R01 · FY2025 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$72,891
R01 · FY2025 · CA
High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease$566,543
R01 · FY2024 · AG · contact PI
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$448,604
R01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$69,246
R01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$69,246
R01 · FY2024 · CA
High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease$566,543
R01 · FY2023 · AG · contact PI
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$462,770
R01 · FY2023 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$28,146
R01 · FY2023 · CA
Artificial Intelligence Driven Platform for PET/MR Imaging$763,919
R56 · FY2022 · EB
High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease$566,543
R01 · FY2022 · AG · contact PI
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$462,770
R01 · FY2022 · CA
Highly Sensitive and Robust Blood Test Platform for Screening and Early Detection of Alzheimer's Disease$399,840
R43 · FY2022 · AG
PET Imaging Agents for Protoporphyrin IX$215,101
R21 · FY2022 · CA
High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease$577,983
R01 · FY2021 · AG · contact PI
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer$486,085
R01 · FY2021 · CA
A New Class of Magnetic Nanoparticles for Glioma Targeted Drug Delivery$400,000
R41 · FY2021 · CA
Small Intestine Targeted Fast Acting Oral Insulin Formulation$299,931
R41 · FY2021 · DK
PET Imaging Agents for Protoporphyrin IX$182,568
R21 · FY2021 · CA
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma$436,882
R01 · FY2020 · CA · contact PI
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles$411,268
R01 · FY2020 · CA
Serum Detection of Medulloblastoma Metastasis$319,726
R41 · FY2020 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$469,682
U01 · FY2019 · CA
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma$420,865
R01 · FY2019 · CA · contact PI
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles$398,930
R01 · FY2019 · CA
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles$369,115
R01 · FY2019 · CA
Integrated Whole Body PET-MRI Scanner$2,000,000
S10 · FY2018 · OD · contact PI
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$511,061
U01 · FY2018 · CA
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma$413,689
R01 · FY2018 · CA · contact PI
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles$411,268
R01 · FY2018 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$595,122
U01 · FY2017 · CA
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma$427,689
R01 · FY2017 · CA · contact PI
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles$411,268
R01 · FY2017 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients$375,455
R01 · FY2017 · CA · contact PI
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$56,018
U01 · FY2017 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$729,411
U01 · FY2016 · CA
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles$425,268
R01 · FY2016 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients$375,455
R01 · FY2016 · CA · contact PI
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$56,018
U01 · FY2016 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy$574,292
U01 · FY2015 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$390,270
R01 · FY2015 · CA · contact PI
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients$375,455
R01 · FY2015 · CA · contact PI
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$15,751
R01 · FY2015 · CA · contact PI
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer$395,425
U01 · FY2014 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$379,123
R01 · FY2014 · CA · contact PI
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients$364,191
R01 · FY2014 · CA · contact PI
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$100,750
R01 · FY2014 · CA · contact PI
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer$471,193
U01 · FY2013 · CA
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients$375,455
R01 · FY2013 · CA · contact PI
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$367,956
R01 · FY2013 · CA · contact PI
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$88,115
R01 · FY2013 · CA · contact PI
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$392,047
R01 · FY2012 · CA · contact PI
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer$391,244
U01 · FY2012 · CA
uPAR Targeted in Vivo Molecular Magnetic Resonance Imaging of....$155,585
P50 · FY2012 · CA · contact PI
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer$438,285
U01 · FY2011 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer$405,027
R01 · FY2011 · CA · contact PI
uPAR Targeted in Vivo Molecular Magnetic Resonance Imaging of....$172,624
P50 · FY2011 · CA · contact PI
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer$471,517
U01 · FY2010 · CA
uPAR Targeted in Vivo Molecular Magnetic Resonance Imaging of....$218,406
P50 · FY2010 · CA · contact PI
Magnetic Resonance Spectroscopy Based Metabolomics for Alzheimer's Disease$157,831
R21 · FY2010 · AG · contact PI
uPAR Targeted in Vivo Molecular Magnetic Resonance Imaging of....$214,357
P50 · FY2009 · CA · contact PI
Magnetic Resonance Spectroscopy Based Metabolomics for Alzheimer's Disease$132,328
R21 · FY2009 · AG · contact PI
uPAR Targeted in Vivo Molecular Magnetic Resonance Imaging of....$135,857
P50 · FY2008 · CA · contact PI
Res Proj 3: uPAR-Targeted in Vivo Molecular Magnetic Resonance Imaging of...$53,455
P20 · FY2007 · CA · contact PI